Migraine
Not recruitingStudy on Rimegepant for Treating Migraine in Adults Who Cannot Use Triptans
- Disease:Migraine
- Substances:Rimegepant
Austria- Participants:18–64 years · 65+ years
- Substances:Rimegepant
- Sponsor:Pfizer Inc.
Rare diseases
Investigational molecules
Locations
Back to Austria59 clinical trials in Klagenfurt am Wörthersee, Austria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Austria
Austria
Austria
Austria
Austria
Austria
Austria
Austria
Austria
Austria
Austria
AustriaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on hepatocellular carcinoma and non-small cell lung cancer, evaluating novel immunotherapy combinations and targeted treatments for improved patient outcomes.
Research includes innovative approaches combining immunotherapy with conventional treatments for various cancer types.
Clinical trials investigating treatments for atrial fibrillation, myocardial infarction, and cardiac conditions, focusing on preventing strokes and improving heart function.
Innovative approaches to treating and managing various cardiovascular conditions using both established and experimental medications.
Studies examining new treatments for multiple sclerosis and migraine headaches, with emphasis on improving patient quality of life and disease management.
Focus on developing targeted therapies for various neurological conditions affecting patients globally.
Research into interstitial lung diseases and community-acquired pneumonia, including COVID-19 related respiratory conditions.
Advanced therapeutic approaches for both acute and chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.